Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB218352 pandemic influenza A vaccine in individuals over 60
NCT00306995Phase 2Completed
- Sponsor
- GSK
- Start
- May 2005
- Primary completion
- Jul 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) in Influenza A subtype H9N2 (H9N2), sponsored by GSK. Started May 2005; status: completed.
02
Drugs
prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
03
Conditions
Influenza A subtype H9N2 (H9N2)
Beyond the preview
Go deeper on NCT00306995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306995.